bismuth subcit k-metronidazole-tetracycline oral brand names and other generic formulations include:
dronabinol oral brand names and other generic formulations include:
bismuth subcit k-metronidazole-tetracycline oral and dronabinol oral
bismuth subcit k-metronidazole-tetracycline oral increases toxicity of dronabinol oral by inhibiting the metabolism of an enzyme (aldehyde dehydrogenase) needed in the body during alcohol intoxication. Dronabinol oral solution (Syndros) contains alcohol, which can produce a disulfiram like reaction if combined with metronidazole. Discontinue metronidazole at least 14 days before starting dronabinol solution and do not administer metronidazole within 7 days of completing treatment with dronabinol solution.
bismuth subcit k-metronidazole-tetracycline oral and dronabinol oral
bismuth subcit k-metronidazole-tetracycline oral increases toxicity of dronabinol oral by aldehyde dehydrogenase inhibition. Dronabinol oral solution (Syndros) contains 50% (w/w) dehydrated alcohol 5.5% (w/w) propylene glycol, which can produce disulfiramlike reactions if coadministered with metronidazole. Discontinue metronidazole at least 14 days before starting dronabinol solution and do not administer metronidazole within 7 days of completing treatment with dronabinol solution.
Check for more interactions with the Drug Interaction Checker
Drug Interaction Categories
Contraindicated
Never use this combination of drugs because of high risk for dangerous interaction
Serious
Potential for serious interaction; regular monitoring by your doctor required or alternate medication may be needed
Significant
Potential for significant interaction (monitoring by your doctor is likely required)
Minor
Interaction is unlikely, minor, or nonsignificant